Modulation of colony stimulating factor release and apoptosis in human colon cancer cells by anticancer drugs

British Journal of Cancer

Volumn 86, Issue 8, 2002, Pages 1316-1321

  Calatayud, S ^a   Warner, T D ^b   Mitchell, J A ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anticancer drugs; Apoptosis; Colonic cells; Colony stimulating factors

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; MERCAPTOPURINE; METHOTREXATE; PACLITAXEL; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CARCINOGENICITY; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; COLONIC NEOPLASMS; COLONY-STIMULATING FACTORS; CYCLOHEXIMIDE; CYTOKINES; HUMANS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0037156956     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600240     Document Type: Article

References (21)

1. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor
2. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells
3. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages
4. Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: Role of cyclo-oxygenase inhibitors
5. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo
6. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
7. Gene transfer as cancer therapy
8. Gene immunotherapy in murine acute myeloid leukemia: Granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines
9. Immunotherapy and gene therapy of cancer
10. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils
11. Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: Enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha
12. Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects
13. Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages
14. Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis
15. Defective monocyte killing in patients with malignancies and restoration of function during chemotherapy
16. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma
17. Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity
18. Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity
19. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells
20. Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53
21. Production of interleukin-1 and tumor necrosis factor by bone marrow-derived macrophages: Effect of cisplatin and lipopolysaccharide